This indicates that our results translate from preclinical research to human (lung) cancer patients and that targeting EPOR specifically in cancer cells may provide a new approach to control the expression of mitochondria in cancer cells and thus, tumor metabolism. The gene discussed is EPOR; the disease is neoplasm.